RET and neoplasm: MTC is reported to exhibit low PD-L1 expression in both tumor cells and tumor-infiltrating immune cells (17–19) and no microsatellite instability, irrespective of the presence/absence of either desmoplasia, lymph node metastases and/or RET mutation (18, 20).